Boston Scientific Aktie
WKN: 884113 / ISIN: US1011371077
|
29.07.2026 12:35:43
|
Boston Scientific Corp Profit Advances In Q2
(RTTNews) - Boston Scientific Corp (BSX) revealed earnings for its second quarter that Increases, from the same period last year
The company's bottom line totaled $907 million, or $0.61 per share. This compares with $797 million, or $0.53 per share, last year.
Excluding items, Boston Scientific Corp reported adjusted earnings of $1.275 billion or $0.86 per share for the period.
The company's revenue for the period rose 7.5% to $5.442 billion from $5.061 billion last year.
Boston Scientific Corp earnings at a glance (GAAP) :
-Earnings: $907 Mln. vs. $797 Mln. last year. -EPS: $0.61 vs. $0.53 last year. -Revenue: $5.442 Bln vs. $5.061 Bln last year.
-Guidance: Next quarter EPS guidance: $ 0.80 To $ 0.82 Next quarter revenue guidance: 3 % To 5 % Full year EPS guidance: $ 3.28 To $ 3.32 Full year revenue guidance: 5.5 % To 6.5 %
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Boston Scientific Corp.
Analysen zu Boston Scientific Corp.
Aktien in diesem Artikel
| Boston Scientific Corp. | 40,80 | 1,48% |
|